New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]

from כל תכני עושים היסטוריה · host רשת עושים היסטוריה

MDS experts Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss new trials presented in the last meeting of the American Society of Hematology (ASH) 2023. They focus on luspatercept, imetelstat and roxodustat.

What this episode covers

NOW PLAYING

0:00 27:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of כל תכני עושים היסטוריה?

This episode is 27 minutes long.

When was this כל תכני עושים היסטוריה episode published?

This episode was published on March 27, 2024.

What is this episode about?

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this כל תכני עושים היסטוריה episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!